LifeFlexIA generates $2.58K/mo revenue with an exceptional 92% profit margin and a highly attractive 1.58x annual profit multiple—well below typical SaaS benchmarks. The listing is verified on TrustMRR with complete financial transparency. At only 4 months old, the business demonstrates rapid profitability and clean unit economics. However, a buyer should confirm customer acquisition channels, churn/retention behavior, and whether the $2.38K monthly profit is sustainable or benefits from launch-phase tailwinds.
The core AI image generation software can be built using OpenAI APIs, Stable Diffusion via API, or similar cloud-based generative models, plus a Next.js or React frontend and Stripe billing—achievable in 10 weeks and $8K–$18K in hard costs (AI API subscriptions, hosting, domain, and templates). However, you are acquiring $2.38K of verified monthly profit, a 4-month track record of customer traction, proof of B2C product-market fit, and an operational business ready to scale—assets that carry far more value than the software alone. The $45K asking price equates to less than 19 months of profit recovery, an extremely attractive entry point for a cash-flowing SaaS asset. Unless the buyer has exceptional AI product chops and can reach equivalent customer density and monetization in parallel, buying is the lower-risk, faster path to profitable cash flow.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
LifeFlexIA — AI Lifestyle Image Generation SaaS LifeFlexIA is a B2C SaaS similar to Halo AI, allowing users to generate ultra-realistic AI photos of themselves in premium lifestyle settings — private
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.